Patent ID: 9180046
Filing Date: 2015-11-10
Classification: A61F,A61M

Abstract:
1. A sustained release delivery device, the delivery device comprising: a refillable reservoir configured to be implanted into a vitreous chamber of an eye through a sutureless sclerotomy and formed a pliable wall configured to contain a therapeutic agent, wherein one or more apertures formed in the pliable wall allow for sustained flow of the therapeutic agent contained in the refillable reservoir through the one or more apertures into the vitreous chamber at a rate of delivery, and wherein the pliable wall has a first configuration having a first cross-sectional dimension suitable for insertion of the refillable reservoir through the sclerotomy into the vitreous chamber and a second configuration having a second, larger cross-sectional dimension, wherein therapeutic agent flows from the reservoir through the one or more apertures in the pliable wall when in the second configuration so as to deliver the therapeutic agent to the vitreous chamber over an extended period of time at the rate of delivery; an inlet port positioned near a proximal end of the refillable reservoir having an injectable, self-sealing surface; and an elongated, inner support around which at least a portion of the pliable wall is configured to adopt the first configuration, the inner support comprising a proximal end extending towards the inlet port and a distal end that is external to the pliable wall.